Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 30 Neoplasm Metastasis 4 Advanced Breast Cancer 4 Triple Negative Breast Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasms 3 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Infertility 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sexual Dysfunctions, Psychological 1 Recurrence 1 Pathologic Complete Response 1 Neoplasms by Site 1 Leiomyoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 HR+/HER2- Breast Cancer 1 HER2 Negative Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal 1 Breast Neoplasm Female 1 Breast Diseases 1

Interventions

Tamoxifen 4 Specimen Handling 4 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Radiotherapy 1 Radiation 1 Omacor 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laser Therapy 1 Biopsy 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Letrozole × 30 days × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡